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Abstract—
Objectives: Trial registries can be used to measure reporting biases and support systematic reviews but 45% of registrations do not
provide a link to the article reporting on the trial. We evaluated the use of document similarity methods to identify unreported links
between ClinicalTrials.gov and PubMed.
Study Design and Setting: We extracted terms and concepts from a dataset of 72,469 ClinicalTrials.gov registrations and 276,307
PubMed articles, and tested methods for ranking articles across 16,005 reported links and 90 manually-identified unreported links.
Performance was measured by the median rank of matching articles, and the proportion of unreported links that could be found by
screening ranked candidate articles in order.
Results: The best performing concept-based representation produced a median rank of 3 (IQR 1-21) for reported links and 3 (IQR
1-19) for the manually-identified unreported links, and term-based representations produced a median rank of 2 (1-20) for reported
links and 2 (IQR 1-12) in unreported links. The matching article was ranked first for 40% of registrations, and screening 50 candidate
articles per registration identified 86% of the unreported links.
Conclusions: Leveraging the growth in the corpus of reported links between ClinicalTrials.gov and PubMed, we found that document
similarity methods can assist in the identification of unreported links between trial registrations and corresponding articles.
Index Terms—Clinical trial reporting, bibliographic databases, ClinicalTrials.gov, document similarity.
F
1 BACKGROUND
C LINICAL trial registries were established to track theconduct of clinical trials and make basic information
about trials publicly available. A number of policies
now mandate prospective registration for clinical studies
of regulated interventions [1-3]. ClinicalTrials.gov is a
US-based registry for clinical studies and is the largest
single database of trial registrations. ClinicalTrials.gov also
links registrations to published results by connecting to
research articles indexed in bibliographic databases [4,5].
This linkage is achieved using a unique identifier (the NCT
Number) for each study. Publishers may include the NCT
number in the abstract or full text of published articles, and
the metadata stored by PubMed, which provides access to
a bibliographic database with information for more than 26
million biomedical articles.
While the introduction of trial registries has been
invaluable for monitoring trial reporting, a substantial
proportion of trials reports remain disconnected from their
registrations. In a 2012 study examining the quality of
linking in ClinicalTrials.gov, 44% of registrations without
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linked publications were found to have corresponding
published articles found by manual searches [7]. In a
systematic review of studies that examine reported and
unreported links between registrations and articles, the
median proportion of registrations with reported links
was 23% and the median proportion of unreported links
(those that required manual searches) was 17%, with the
remainder unpublished [6].
The quality of this linkage between bibliographic
databases and trial registries affects the time it takes to
measure reporting biases. This includes determining which
clinical studies remain unpublished [8-12], or comparing
registered outcomes with what is reported in published
articles [13-21]. Without comprehensive linking, research
to evaluate reporting biases must instead rely on time-
consuming manual searches to identify unreported links.
The presence of unreported links also limits the value
of trial registries for systematic reviews. If links between
registrations and articles were comprehensive, registrations
could be more effectively used to automate the identification
of trials for inclusion in systematic reviews [22,23], as well
as provide early signals that a systematic review should be
updated [24-33].
Our aim in this study was to evaluate whether we could
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2use information contained in the recorded links between
ClinicalTrials.gov registrations and PubMed articles to help
identify unreported links. The longer-term goal is to develop
robust methods to identify all published research associated
with a trial registration, whether or not links are provided
in the registration record.
2 METHODS
In the following experiments, we use similarities in the
text from registrations in ClinicalTrials.gov and articles in
PubMed. Using the set of reported links as a baseline, we
test a series of different methods to represent the text as
features, and assign weights to each of the features. The
resulting set of features are used to produce an automatic,
weighted search query for use in PubMed, where the
objective is to rank the matching article as high as possible
in a list of candidate articles. The approach is expected to
replace the need for an expert to construct search queries in
PubMed for every registration without a link to a published
article.
2.1 Study data
We included trial registrations in ClinicalTrials.gov for
trials that were received by ClinicalTrials.gov on or after 1
October 2007, were marked as completed, and described an
interventional study. The date was selected to correspond
to the passing of the Food and Drug Administration
Amendments Act of 2007, which expanded registration
requirements for studies registered with ClinicalTrials.gov.
A final search of ClinicalTrials.gov was conducted on April
14 2017. Data extracted from registrations included titles,
trial summaries, and conditions studied.
We next selected all articles indexed in PubMed that
reported a clinical trial and were published on or after
October 1 2007. Articles were assumed to be reporting
the results of trials if they included a ClinicalTrials.gov
NCT Number as a secondary source identifier or listed
“clinical trial”, “controlled clinical trial”, or “randomized
controlled trial” as a publication type, and did not include
“meta-analysis” or “review” as a publication type. A final
search was conducted on April 14 2017. Data extracted
from each PubMed article entry included the title text,
abstract text, and any NCT Numbers stored as a secondary
source identifier in the metadata. Where PubMed entries
included NCT Numbers as secondary source identifiers,
we described these as reported links and created a dataset
comprising the set of registrations with known links from
one or more articles.
We then created a second set of registrations for testing,
comprising 90 registrations that had unreported links to trial
articles identified by manually checking 200 registrations
with trial completion dates between January 1 2007 and
December 31 2015. The 200 registrations had no reported
links to trial articles in PubMed at the time of the search.
We manually searched PubMed and other bibliographic
databases to identify articles that reported the results of the
trials, following a search strategy previously described and
common to studies examining outcome reporting biases [6].
The search uses study design information, investigator
names, locations, and other identifying features to search
PubMed for the matching article. To confirm a match, we
compared the number of participants, the study design and
the length of the study, and any information about when
and where the trial was undertaken. Where there were
multiple matches, we selected the article published closest
to the completion date of the trial.
2.2 Feature representations and distance measures
Data elements were extracted for each registry entry
including brief title, detailed title, brief summary, detailed
summary, and condition. Articles were represented by the
text of the titles and abstracts in PubMed.
A term-based representation of registrations and trial
reports was created using the set of extracted words
after removing punctuation. Using existing methods for
extracting concepts from free text [34-40], we also created
a concept-based representation where each document was
represented by the set of clinical concepts. These concepts
were produced by MetaMap [41], which identifies concepts
from the Unified Medical Language System (UMLS). We
used a local MetaMap server that recognised concepts from
the 2014AA UMLS release, and used MetaMap with word
sense disambiguation. This method uses a term’s context
in a sentence to address the ambiguity of words with
multiple meanings. The concept that was ranked highest by
MetaMap for each phrase in the text was recorded.
We did not use information related to investigators,
funding, or authors to allow unbiased testing of these
document similarity measures. While investigator names,
numbers of participants, and funding information are all
useful for determining whether a published article describes
a trial from a registration, it would need to be implemented
differently from the terms and concepts used here and
could introduce biases in the estimation of publication rates
for studies with different funding sources.
For both the term and concept-based representations,
we tested two ways to assign values to each of the features.
A binary vector representation captured the presence or
absence of a given feature (term or concept) in a document.
A term frequency-inverse document frequency (tf-idf ) vector
representation was also calculated [42,43], given by the
product of the number of times the feature appears in the
document (log-transformed) and the inverse document
frequency, which is given by the inverse of the proportion
of documents in which the feature appears (also log-
transformed). The log transformations are typically applied
to the tf-idf calculation to help to ensure that individual
terms or concepts that are used frequently in very few
registrations and articles do not dominate the document
similarity calculations described below.
We evaluated the performance of three standard
pairwise measures of distance between the vectors
3representing registrations and the vectors representing trial
reports. The normalised Euclidean distance is given by the
straight-line distance between the two vectors representing
a registry entry and an article, divided by the number of
features present in the article. The cosine similarity is the
cosine of the angle between the two vectors representing
a registry entry and an article. The Jaccard distance is the
number of features present in both a registration vector and
article trial report vector, divided by the number of features
present in either vector.
For each registry entry, we produced a ranked list of
PubMed articles, created by sorting the set of all articles
by their distance from the registration. Where a registry
entry had known links from more than one trial report in
PubMed, we determined the rank for the first linked trial
report published after the completion date of the trial.
2.3 Performance measures
Performance was assessed using the final ranks of the linked
(reported or unreported) trial reports, reported as median
and interquartile range. We additionally determined the
proportion of registrations for which the linked (reported
or unreported) trial report was ranked first among all
candidates, and the proportion of registrations for which
the linked (reported or unreported) trial report was within
the first 50 candidates (recall@50). We also reported the
extension of this measure for recall after checking any
number of candidates (recall@N), as a visual demonstration
of the amount of manual effort required to identify a given
percentage of previously unreported links in a cohort of
registrations. The recall@N is the cumulative proportion of
registrations for which the linked (reported or unreported)
trial report can be found after having read the top N
candidates, and is defined for values between 0 (where the
proportion of found trial reports is always 0) and the total
number of candidates (where the proportion is always 1).
Code for the document similarity methods
are available online via a GitHub repository
(https://github.com/pmartin23/tfidf). The repository
includes scripts for using the document similarity to rank
PubMed articles given a ClinicalTrials.gov NCT Number.
3 RESULTS
We identified 72,469 registrations in ClinicalTrials.gov and
276,307 candidate trial reports in PubMed that met the
inclusion criteria (Figure 1). Among the registrations, 16,005
(22.1%) had one or more links from trial reports published
in the same period (Table 1).
In the set of 200 registrations, 90 were found to have
unreported links to trial reports in PubMed. Of these, 33%
(30 of 90) included the NCT Number in the full text of the ar-
ticle but the identifier was not reported in the PubMed entry
metadata or provided by investigators in ClinicalTrials.gov
(Table 2).
The number of unique concepts found across both
corpora was 490,814, and of these 46,777 were found
TABLE 1: Characteristics of 16,005 trials with completion
dates after October 1 2007 and links from PubMed articles.
Count (% of total)
Trial type
Phase 0 1 2,318 (14.5%)
Phase 2 2,931 (18.3%)
Phase 3 2,842 (17.8%)
Phase 4 2,091 (13.1%)
Unknown 5,823 (36.4%)
Participants
Under 50 4,946 (30.9%)
50-200 5,719 (35.7%)
Over 200 4,990 (31.2%)
Unknown 98 (0.6%)
Funding
Industry only 4,759 (29.7%)
Mixed 1,461 (9.1%)
No industry 9,785 (61.1%)
Total 16,005 (100%)
TABLE 2: Characteristics of 200 trials with completion dates
after January 1 2007 and no reported links to PubMed.
Count (% of
total)
Matching
article in
PubMed (%
of group)
NCT
Number
included in
article (% of
group)
Trial type
Phase 0 & 1 34 (17%) 12/34 (35%) 5/34 (15%)
Phase 2 52 (26%) 29/52 (56%) 7/52 (13%)
Phase 3 35 (18%) 15/35 (43%) 6/35 (17%)
Phase 4 30 (15%) 16/30 (53%) 6/30 (20%)
Unknown 49 (24%) 18/49 (37%) 6/49 (12%)
Participants
Under 50 88 (44%) 40/88 (45%) 13/88 (15%)
50-200 85 (42%) 36/85 (42%) 13/85 (15%)
Over 200 25 (12%) 14/25 (56%) 4/25 (16%)
Unknown 2 (1%) 0/2 (0%) NA
Funding
Industry only 91 (46%) 33/91 (36%) 10/91 (11%)
Mixed 17 (8%) 13/17 (76%) 5/17 (29%)
No industry 92 (46%) 44/92 (48%) 15/92 (16%)
Total 200 (100%) 90/200 (45%) 30/200 (15%)
more than once in both the registrations and the articles
(Figure 2). There were 789,848 unique terms across both
corpora, and of these 78,856 were found more than once in
both the registrations and the articles. After reducing the
sets of concepts and features to include only those that were
found more than once in both the registrations and articles,
the number of remaining concepts varied between 2 and
273 (median 32) per registration, and between 2 and 296
(median 79) in articles. After applying the same process, the
number of remaining terms per registration varied between
2 and 1,576 (median 108), and between 2 and 472 (median
142) for articles.
The median ranks produced by testing combinations of
feature representations and distance measures on reported
links varied substantially (Table 3). There were only small
differences between the median ranks of the term-based
and concept-based representations for the best performing
combination, which in both cases used tf-idf weights and
cosine distances. In both the term-based representation and
the concept-based representation the tf-idf score and co-
sine distance measure placed the linked article first among
all candidates for 40% of registrations (ranked first from
4Fig. 1: The study data included 72,469 registrations from ClinicalTrials.gov and the metadata from 276,307 articles available
in PubMed. A testing set of 200 registrations were manually reviewed and 90 of those were found to have unreported links
to trial reports.
TABLE 3: The effect of using terms or concepts on the per-
formance by feature representation and distance measures
in a set of 16,005 registrations with reported links to articles.
Feature
representations
Median rank
(IQR)
First-
ranked
candi-
date*
Recall@50
Terms (binary)
Euclidean 533 (8-7,900) 17.2% 34.4%
Jaccard 6 (1-160) 34.8% 67.1%
Cosine 4 (1-81) 37.4% 71.9%
Terms (tf-idf)
Euclidean 363 (3-15,110) 18.5% 40.2%
Cosine 2 (1-20) 40.2% 83.2%
Concepts (binary)
Euclidean 25 (1-1,679) 28.8% 54.2%
Jaccard 11 (1-191) 28.3% 64.1%
Cosine 6 (1-89) 32.2% 70.9%
Concepts (tf-idf)
Euclidean 97 (2-7,230) 23.1% 46.9%
Cosine 3 (1-21) 39.6% 82.3%
*The first ranked candidate was the article that reported the results of
the trial in the registration.
among 276,307 candidate trial reports), and within the top
50 ranked trial reports (ranked ≤50 from 276,307 candidate
trial reports) for 83% of the registrations.
The results were similar in the 90 registrations with
unreported links to trial articles, which were used to test
the method in a practical setting. The best-performing
combinations used the tf-idf score and the cosine distance
measure (Table 4), and the term-based and concept-based
TABLE 4: The effect of using terms or concepts on the perfor-
mance by feature representation and distance measures in a
set of 90 registrations with unreported links to trial reports.
Feature
representations
Median rank
(IQR)
First-
ranked
candi-
date*
Recall@50
Terms (binary)
Euclidean 5,030 (225-25,675) 8.2% 16.5%
Jaccard 16 (1-342) 30.6% 62.4%
Cosine 12 (1-206) 34.1% 67.1%
Terms (tf-idf)
Euclidean 832 (6-29,048) 12.9% 38.8%
Cosine 2 (1-12) 40.0% 85.9%
Concepts (binary)
Euclidean 221 (2-7,386) 22.4% 41.2%
Jaccard 17 (2-383) 24.7% 61.2%
Cosine 8 (1-92) 25.9% 69.4%
Concepts (tf-idf)
Euclidean 291 (2-19,387) 17.6% 40.0%
Cosine 3 (1-19) 29.4% 82.4%
representations produced similar results. The maximum
recall@50 was 85.9% for terms and 82.4% for concepts.
For other combinations of scores and distance measures,
concept-based representations generally outperformed the
equivalent term-based representations (Figure 3).
4 DISCUSSION
The results demonstrate that relatively simple represen-
tations across shared terms or concepts can be used to
5Fig. 2: The distribution of 490,814 concepts (left) and 789,848 terms (right) that were present in 276,307 articles (top) and
the 72,469 registrations (bottom).
support the identification of unreported links between a
trial’s registration and the article reporting its results. For
two in five registrations, the method ranks the matching
article first among all candidates. For more than four in
every five registrations, a user would only need to check
50 candidates to identify an unreported link to its matching
article.
4.1 Comparisons with prior research
To the best of our knowledge no other methods have been
proposed to automate the identification of unreported
links between trials’ registrations and the articles reporting
their results. The most closely related research in the
application domain is a method for identifying multiple
publications from the same clinical trial [44]. Conceptually,
the method is similar to concept-mapping that is used
in certain search methods [45], but differs because it
produces what is effectively an automated and weighted
query using the language of registrations rather than
requiring users to author queries themselves. Related
research in clinical epidemiology includes technologies
that operate on bibliographic databases to support
the screening of articles for inclusion in a systematic
review [22]. Recent developments included supervised,
unsupervised, and hybrid methods [37,46,47], and several
have taken advantage of semantic similarities between
documents [48,49].
Our results on rates of reported and unreported links are
consistent with previous observational studies examining
ClinicalTrials.gov and PubMed. A series of studies showed
that 27.8% of 8,907 registrations for completed, interven-
tional, Phase 2 or later trials were found to have one or more
machine-readable links to PubMed, and 44% of a sample of
50 registrations without known links were found to have
matching trial reports [7,50,51].
4.2 Implications
Our methods support novel approaches to the system-
wide monitoring of trial reporting. A number of studies
have used ClinicalTrials.gov to examine reporting biases,
including both publication bias and outcome reporting
bias [6,52]. In these studies, investigators relied on the
manual identification of links between registrations and
6Fig. 3: Recall@N for term and concept based feature representations among the set of 90 registrations with unreported
links to trial reports. The proportions of unreported links that were found by checking the first candidate (and first 50
candidates) are indicated by the two vertical lines.
published articles to ensure that all published results were
identified. This is a time-consuming and rate limiting
step. By replacing the need for experts to construct search
queries in PubMed for each registration without a link to a
published article, our proposed approach could be used to
reduce the expertise and time needed to identify unreported
links between trial registrations and the articles that report
their results. Because there are still a substantial proportion
of links that remain unreported, and this proportion does
not appear to have changed over time, the method is likely
to be of continued value until existing registrations are
comprehensively linked to their results.
In a systematic review of studies that examine both
reported and unreported links between trial registrations
and articles, the results indicated that there was a smaller
proportion of unreported links when investigators started
from a cohort of articles and tried to find links to registra-
tions. This appeared to be because articles often included
trial registry identifiers in the full text of articles that were
not included in the metadata in bibliographic databases [6].
We found a similar result: for 30 of 90 unreported links, the
NCT Number was available in the full text of the article. All
stakeholders, including the trial investigators, the journals,
the bibliographic databases, and the organisations funding
the trials could improve the number of links available in
metadata, either by adding the information directly to Clin-
icalTrials.gov, or by ensuring the information is available in
the metadata provided to PubMed.
The research also has implications for automating sys-
tematic review processes. Methods designed to help system-
atic reviewers identify articles for inclusion in systematic
reviews often use machine learning to replicate human
screening of articles. The best-performing methods in this
area are able to reduce workload by between 30% to 70%
with an estimated loss of 5% of relevant studies [22].
Comprehensive matching of registrations and trial reports
could provide a more reliable and complete basis from
which to develop methods for automating systematic re-
view processes. Rather than relying on the minimal descrip-
tions available for articles in bibliographic databases [53],
information from ClinicalTrials.gov could provide an earlier
and more complete description of the trials and yield more
accurate machine learning results for article screening and
selection.
4.3 Limitations and future research
This study has several limitations. In the set of unreported
links, the manual search protocol may not have identified
all published results. If the 90 articles we identified were
easier to find by manual searches because they shared a
larger number of terms, this may have over-estimated the
performance in practice. However, the rate of publication
for these entries was similar to prior reports [6]. It is also
possible that the set of reported links included articles
that were not presenting the results of the trials (such
as pilot studies, protocols, or secondary analyses), which
could influence the performance relative to the manually-
curated studies, which were all selected as the first articles
presenting the results of the trials. To minimise the risk of
including incorrect articles in the set of reported links, we
included the reported link to the article that was published
after the completion date of the trial and excluded studies
that were published before the stated completion date.
7The methods described here represent a series of baseline
results that could be implemented directly in a process for
finding unreported links, but could be improved in several
ways. In particular, to ensure a fair comparison was made
for the two approaches, we only included a limited selection
of the fields available in ClinicalTrials.gov to represent the
registrations. If we had included the names, affiliations, and
countries of the investigators, it is likely that the perfor-
mance of the document similarity method would have in-
creased (but only for the term-based representation because
these fields would not be recognised as UMLS concepts).
Likewise, text from the full articles could have improved
the performance of the method, but only when finding links
to articles published in open access journals. Second, a fur-
ther pre-processing step to reduce the number of candidate
articles may improve the performance, especially where
distance measures perform poorly. Finally, machine learning
methods such as learning to rank approaches could be used
to reduce, re-weight, or transform the sets of features by
training them on the sets of reported links, and this may
also yield improvements in performance given the volume
and rate of growth in the number of reported links that can
be used for training. Further research in this area should
also consider how a user-friendly implementation of the
methods tested here compare to a baseline in which experts
and non-experts construct their own search strategies for
PubMed.
5 CONCLUSION
Information contained in clinical trial registries may be use-
ful for monitoring trial reporting activities and synthesising
evidence, but this type of surveillance remains limited due
to the growing number of incomplete links between Clini-
calTrials.gov and PubMed. Here we evaluate a method for
partially automating the identification of published articles
related to registrations. Our results demonstrate that docu-
ment similarity methods can be used to replace the need to
construct search strategies in a bibliographic database when
trying to identify unreported links. While the approach does
not replace the need to screen the resulting ranked set of
candidates, it demonstrates the potential for automation in
this space.
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